AstraZeneca’s Soriot on cures for pharma ills
The Big View - Un podcast de Reuters - Les mardis
The $208 bln drugmaker’s CEO is celebrating 10 years at the helm. In this edition of the Exchange podcast, he explains why after quadrupling the company’s share price, there is more to do. He also delves into Chinese competition and the consequences of caps on U.S. drug prices.
